REQUEST A DEMO
Total
USD $0.00
Search more companies

Rezidence Hb A.S. (Czech Republic)

Main Activities: Outpatient Care Centers
Full name: Rezidence Hb A.S. Profile Updated: April 24, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Rezidence Hb A.S. is based in Czech Republic. The head office is in Chrast. The enterprise operates in the Outpatient Care Centers industry. The enterprise was incorporated on July 13, 2007. The total number of employees is currently 10 - 19 (2024). The company’s latest financial report indicates a net sales revenue increase of 11.06% in 2024. During that time, Rezidence Hb A.S.’s total assets grew by 4.86%. Rezidence Hb A.S.’s net profit margin decreased by 12.54% in 2024.

Headquarters
Postranni 250
Chrast; Plzensky; Postal Code: 33003

Contact Details: Purchase the Rezidence Hb A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Rezidence Hb A.S. report to view the information.
Registered Capital:
Purchase the Rezidence Hb A.S. report to view the information.
Financial Auditors:
Purchase the Rezidence Hb A.S. report to view the information.
Incorporation Date:
July 13, 2007
Key Executives
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Supervisory Board
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Rezidence Hb A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
11.06%
Total Operating Revenue
11.06%
Operating Profit
-60.95%
EBITDA
-51.17%
Net Profit/Loss for the Period
-64.15%
Total Assets
4.86%
Total Equity
4.55%
Operating Profit Margin
-15.12%
Net Profit Margin
-12.54%
Return on Equity (ROE)
-8.34%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?